TherapeuticsMD (TXMD) Misses Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
TherapeuticsMD Announces First Quarter 2016 Financial Results
May 3, 2016 4:05 PM EDT- NDA filing for TX-004HR planned by end of June 2016 -
- Strong cash position of approximately $182 million to advance pipeline products -
BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative womens healthcare company, today announced its first quarter financial results for the quarter ended March 31, 2016.
First Quarter and Recent Developments
Net revenue from the companys prescription prenatal vitamin business increased 10 percent to approximately $4.9 million for the first quarter of 2016, compared with approximately $4.5 million for... More